|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07D 413/14 | (2006.01) |
| A61K 31/423 | (2006.01) | ||
| A61P 37/00 | (2006.01) |
| (11) | Number of the document | 3774791 |
| (13) | Kind of document | T |
| (96) | European patent application number | 19722310.0 |
| Date of filing the European patent application | 2019-03-29 | |
| (97) | Date of publication of the European application | 2021-02-17 |
| (45) | Date of publication and mention of the grant of the patent | 2022-12-21 |
| (46) | Date of publication of the claims translation | 2023-04-11 |
| (86) | Number | PCT/US2019/025036 |
| Date | 2019-03-29 |
| (87) | Number | WO 2019/191707 |
| Date | 2019-10-03 |
| (30) | Number | Date | Country code |
| 201862650821 P | 2018-03-30 | US | |
| 201862687964 P | 2018-06-21 | US |
| (72) |
WU, Liangxing , US
LI, Jingwei , US
YAO, Wenqing , US
|
| (73) |
Incyte Corporation ,
1801 Augustine Cut-Off, Wilmington, DE 19803,
US
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Hererocikliniai junginiai kaip imunomoduliatoriai |
| HETEROCYCLIC COMPOUNDS AS IMMUNOMODULATORS |
| Payment date | Validity (years) | Amount | |
| 2025-03-28 | 7 | 162.00 EUR |
| 2026-03-29 |